Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

06 Jun 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated June 6, 2022 titled ‘Zydus Lifesciences receives final approval from USFDA for Famotidine Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1911.45
Dr. Reddys Labs. 1387.40
Cipla 1411.95
Lupin 2016.35
Zydus Lifesciences 1225.00
View more..